Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.7 USD | +10.39% | +42.86% | -45.51% |
Business Summary
Number of employees: 11
Managers
Managers | Title | Age | Since |
---|---|---|---|
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 27/03/22 |
Founder | 79 | 31/08/15 | |
Wendy DiCicco
DFI | Director of Finance/CFO | 56 | 18/07/23 |
Miles Nunn
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/15 |
John Neylan
CTO | Chief Tech/Sci/R&D Officer | 70 | 07/11/22 |
Chief Operating Officer | - | 30/06/22 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Williams
BRD | Director/Board Member | 65 | 31/05/16 |
Founder | 79 | 31/08/15 | |
Director/Board Member | 61 | 04/07/23 | |
Samir R. Patel
BRD | Director/Board Member | 55 | 11-28 |
Director/Board Member | 70 | 22/01/18 | |
Jacques Suzanne
CEO | Chief Executive Officer | 53 | 27/03/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 13,234,315,298 | 3,808,858,604 ( 28.78 %) | 0 | 28.78 % |
Company contact information
Akari Therapeutics Plc
22 Boston Wharf Road 7th Floor
02210, Boston
+44 20 8004 0270
http://www.akaritx.comSector
1st Jan change | Capi. | |
---|---|---|
-45.51% | 13.47M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+2.13% | 22.25B | |
-14.77% | 21.68B | |
-8.79% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- AKTX Stock
- Company Akari Therapeutics, Plc